USANA Health Sciences (USNA) stock price, revenue, and financials

USANA Health Sciences market cap is $1.3 b, and annual revenue was $1.06 b in FY 2019

$1.3 B

USNA Mkt cap, 27-Mar-2020

$1.1 B

USANA Health Sciences Revenue FY, 2019
USANA Health Sciences Gross profit (FY, 2019)873.4 M
USANA Health Sciences Gross profit margin (FY, 2019), %82.3%
USANA Health Sciences Net income (FY, 2019)100.5 M
USANA Health Sciences EBIT (FY, 2019)146.2 M
USANA Health Sciences Cash, 28-Dec-2019234.8 M

USANA Health Sciences Revenue

USANA Health Sciences revenue was $1.06 b in FY, 2019

Embed Graph

USANA Health Sciences Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

581.9m648.7m718.2m790.5m918.5m1.0b1.0b1.2b1.1b

Revenue growth, %

10%16%10%

Cost of goods sold

101.7m115.8m127.4m140.8m159.7m180.2m179.4m200.7m187.5m

Gross profit

480.2m532.9m590.7m649.7m758.8m825.9m867.9m988.5m873.4m

Gross profit Margin, %

83%82%82%82%83%82%83%83%82%

Sales and marketing expense

3.9m

R&D expense

4.7m

General and administrative expense

137.1m154.2m166.2m234.2m265.1m275.1m267.7m

Operating expense total

403.0m434.7m474.0m687.3m735.4m800.2m727.2m

Depreciation and amortization

1.5m

EBIT

77.3m98.2m116.7m116.1m141.7m138.6m132.5m188.4m146.2m

EBIT margin, %

13%15%16%15%15%14%13%16%14%

Interest expense

9.0k20.0k131.0k129.0k15.0k70.0k2.1m3.2m4.3m

Interest income

191.0k247.0k464.0k500.0k1.1m1.5m2.2m4.4m4.7m

Pre tax profit

77.5m98.4m116.6m115.7m142.6m138.6m134.6m191.5m150.5m

Income tax expense

26.7m32.0m37.6m39.0m47.9m38.5m72.1m65.3m50.0m

Net Income

50.8m66.4m79.0m76.6m94.7m100.0m62.5m126.2m100.5m

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

148.9m143.5m154.1m160.9m165.2m169.1m189.1m173.7m182.4m188.3m191.9m233.3m219.4m233.2m240.4m258.5m254.2m255.3m257.1m261.8m292.0m301.5m296.8m273.0m256.0m260.6m

Cost of goods sold

26.2m25.2m27.2m28.1m30.3m30.3m31.9m31.5m33.8m34.9m34.6m41.0m38.4m40.1m42.9m46.0m45.0m42.7m43.9m47.1m49.4m50.0m51.9m45.9m46.5m47.8m

Gross profit

122.7m118.3m126.9m132.8m134.8m138.8m157.2m142.2m148.6m153.4m157.4m192.2m181.0m193.2m197.5m212.5m209.2m212.7m213.2m214.6m242.6m251.5m244.9m227.1m209.5m212.8m

Gross profit Margin, %

82%82%82%83%82%82%83%82%81%81%82%82%83%83%82%82%82%83%83%82%83%83%83%83%82%82%

General and administrative expense

33.8m33.4m38.0m36.8m40.3m42.4m43.0m41.1m44.6m43.2m45.5m52.8m49.9m52.5m56.6m59.8m60.6m64.0m62.4m67.3m70.1m67.5m69.1m69.6m66.9m66.3m

Operating expense total

101.6m99.5m106.0m107.7m110.7m112.3m120.8m117.5m123.5m124.3m128.1m154.3m151.2m154.4m164.0m175.1m173.4m179.8m180.8m183.3m199.5m200.3m199.4m192.1m178.4m177.3m

EBIT

21.2m18.8m20.9m25.2m24.1m26.6m36.5m24.7m33.5m37.4m35.8m32.9m32.4m31.4m51.1m45.5m35.0m31.2m35.5m

EBIT margin, %

14%13%14%16%15%16%19%14%14%14%14%13%13%12%17%15%13%12%14%

Interest expense

2.0k1.0k132.0k222.0k11.0k26.0k83.0k76.0k6.0k5.0k4.0k6.0k7.0k496.0k219.0k268.0k482.0k460.0k690.0k10.0k388.0k1.0m1.3m1.4m430.0k

Interest income

54.0k42.0k38.0k71.0k75.0k78.0k81.0k119.0k212.0k215.0k8.0k367.0k154.0k232.0k438.0k323.0k338.0k483.0k590.0k571.0k840.0k1.0m1.3m1.5m1.3m966.0k

Pre tax profit

21.2m18.9m21.0m24.9m24.4m26.5m36.4m24.8m25.2m29.4m29.0m38.4m30.0m38.7m33.0m37.7m36.1m33.4m32.8m32.0m44.0m51.5m46.5m36.3m32.5m35.9m

Income tax expense

7.3m6.5m7.2m8.2m6.9m8.8m12.2m8.0m8.7m10.1m9.5m12.8m10.3m13.3m10.7m11.9m6.0m12.0m9.6m8.3m15.0m17.6m15.5m12.1m11.1m11.7m

Net Income

13.9m12.4m13.8m16.7m17.5m17.8m24.2m16.8m16.5m19.3m19.5m25.6m19.7m25.4m22.3m25.8m30.1m21.4m23.3m23.8m28.9m33.9m31.0m24.2m21.4m24.2m

USANA Health Sciences Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

50.4m70.8m137.3m111.1m143.2m175.8m247.1m214.3m234.8m

Accounts Receivable

3.4m

Prepaid Expenses

18.7m25.2m35.8m30.1m32.5m25.5m

Inventories

37.0m36.5m47.2m45.2m66.1m64.8m62.9m81.9m68.9m

Current Assets

106.1m132.5m229.0m190.9m244.3m277.9m340.2m392.3m329.3m

PP&E

60.8m61.8m59.2m71.2m88.0m101.3m102.8m92.0m95.2m

Goodwill

17.7m17.9m18.2m17.9m17.4m16.7m17.4m16.8m16.6m

Total Assets

244.5m267.4m368.5m350.6m423.2m470.6m519.3m554.5m516.9m

Accounts Payable

8.0m7.0m9.5m7.8m10.0m9.0m11.8m9.9m12.5m

Short-term debt

2.7m

Current Liabilities

59.7m70.8m95.9m108.7m131.4m138.5m141.2m148.7m136.1m

Long-term debt

60.0m

Total Debt

62.7m

Common Stock

15.0k14.0k14.0k24.0k24.0k22.0k

Additional Paid-in Capital

49.3m43.8m54.7m61.6m69.7m71.5m76.5m72.0m59.4m

Retained Earnings

118.8m134.8m200.0m166.4m214.9m265.4m288.1m329.5m306.1m

Total Equity

173.9m185.6m260.5m230.2m280.9m325.3m363.2m391.1m351.7m

Debt to Equity Ratio

0.3 x

Debt to Assets Ratio

0.2 x

Financial Leverage

1.4 x1.4 x1.4 x1.5 x1.5 x1.4 x1.4 x1.4 x1.5 x

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

24.9m36.3m71.2m65.5m76.6m71.0m96.1m115.3m142.7m118.3m87.7m174.2m128.6m150.9m150.5m112.4m134.5m176.3m229.4m191.7m266.2m256.3m239.8m225.0m231.4m182.7m

Prepaid Expenses

16.3m17.5m18.9m24.2m28.8m19.6m28.3m35.1m25.3m38.1m39.4m33.2m32.1m31.4m31.8m31.8m32.2m31.8m26.3m24.1m

Inventories

35.4m36.2m35.3m33.8m33.3m43.0m41.7m45.7m46.9m44.5m42.6m61.6m51.0m54.0m67.6m71.3m74.1m69.7m68.7m63.3m68.1m74.1m81.1m86.5m88.1m76.1m

Current Assets

79.3m90.0m125.3m123.5m138.7m133.7m166.0m196.1m226.4m201.9m162.5m269.8m211.5m244.8m243.4m221.9m248.1m279.2m330.2m286.5m366.1m404.7m434.8m370.2m348.8m283.0m

PP&E

60.6m59.8m61.2m60.3m62.1m60.7m58.8m60.4m58.8m65.9m66.3m78.5m73.4m73.9m94.6m94.7m103.9m102.0m102.5m102.1m101.4m96.8m93.6m92.0m92.6m91.5m

Goodwill

16.9m17.6m17.8m17.7m17.8m17.9m18.0m18.1m17.9m17.9m18.1m17.7m18.1m17.9m17.5m17.2m17.1m16.8m17.0m17.2m17.8m17.2m16.8m17.1m16.8m16.5m

Total Assets

205.9m229.3m264.5m261.0m274.3m268.7m298.9m331.3m371.5m354.9m316.9m438.9m375.0m408.5m431.7m409.7m443.6m472.0m524.8m490.7m545.9m575.3m599.4m551.6m532.4m463.0m

Accounts Payable

8.3m9.1m7.6m6.4m6.9m8.2m7.3m8.1m6.1m6.4m6.6m9.5m9.5m9.0m8.0m10.1m10.6m8.8m7.4m9.3m12.7m12.4m14.5m11.7m11.7m8.6m

Short-term debt

1.2m

Current Liabilities

54.5m59.3m62.4m66.7m66.8m70.0m74.6m82.5m79.9m88.7m105.5m114.5m110.4m112.9m112.8m128.0m128.4m110.9m135.4m121.4m126.4m136.8m152.9m130.0m128.8m129.6m

Long-term debt

66.0m

Total Debt

66.0m1.2m

Common Stock

15.0k15.0k15.0k14.0k14.0k14.0k14.0k14.0k12.0k12.0k12.0k24.0k24.0k24.0k24.0k24.0k24.0k23.0k23.0k22.0k

Additional Paid-in Capital

46.9m46.8m52.3m47.7m49.3m42.0m45.8m52.8m58.4m51.9m38.6m78.2m64.7m71.7m59.6m64.4m68.9m75.7m79.5m73.0m79.4m83.5m83.2m69.1m68.8m56.9m

Retained Earnings

98.8m106.2m132.6m130.1m141.0m138.8m163.0m179.7m216.6m197.0m155.7m237.1m186.1m211.5m187.7m213.4m243.5m286.8m310.0m293.9m315.7m349.6m362.3m329.0m327.5m275.4m

Total Equity

150.4m159.1m191.1m183.6m197.0m187.6m214.0m238.6m279.7m254.3m199.4m313.4m253.3m284.5m244.9m273.9m307.7m353.9m383.1m362.8m401.0m429.3m435.6m391.2m384.2m314.3m

Debt to Equity Ratio

0.3 x0 x

Debt to Assets Ratio

0.2 x0 x

Financial Leverage

1.4 x1.4 x1.4 x1.4 x1.4 x1.4 x1.4 x1.4 x1.3 x1.4 x1.6 x1.4 x1.5 x1.4 x1.8 x1.5 x1.4 x1.3 x1.4 x1.4 x1.4 x1.3 x1.4 x1.4 x1.4 x1.5 x

USANA Health Sciences Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

50.8m66.4m79.0m76.6m94.7m100.0m62.5m126.2m100.5m

Depreciation and Amortization

8.5m8.8m9.0m8.8m10.0m13.5m16.1m16.8m14.7m

Accounts Receivable

Inventories

(3.2m)1.4m(11.8m)1.1m(23.0m)(1.0m)6.1m(23.1m)13.0m

Accounts Payable

1.5m(985.0k)2.8m(1.3m)2.5m(1.3m)3.0m(1.7m)1.8m

Cash From Operating Activities

70.1m92.8m98.9m105.2m111.5m137.0m123.8m152.1m126.7m

Purchases of PP&E

(10.6m)(8.4m)(8.1m)(20.4m)(23.7m)(32.7m)(13.2m)(11.4m)(16.6m)

Cash From Investing Activities

(10.6m)(8.3m)(21.6m)(16.3m)(25.1m)(31.9m)(12.9m)(69.0m)47.5m

Short-term Borrowings

(1.8m)(73.7m)(3.5m)(5.0m)

Cash From Financing Activities

(33.4m)(64.5m)(10.2m)(113.0m)(49.2m)(64.9m)(50.3m)(105.3m)(152.1m)

Net Change in Cash

26.1m20.5m66.5m32.6m71.4m(33.3m)20.5m

Interest Paid

10.0k20.0k1.0k136.0k15.0k323.0k16.0k6.0k11.0k

Income Taxes Paid

24.5m27.1m27.0m27.0m35.8m52.6m46.0m70.7m54.9m

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q3, 2015Q1, 2016Q2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

25.2m37.6m13.8m30.5m48.0m17.8m42.0m58.7m16.5m19.3m19.5m25.6m19.7m25.4m22.3m48.1m78.2m21.4m44.6m68.4m28.9m62.9m24.2m45.6m69.8m

Depreciation and Amortization

4.2m6.4m2.2m4.4m6.6m2.3m4.6m6.9m3.5m6.8m9.9m3.5m7.7m11.8m4.5m8.7m3.9m7.7m11.2m

Inventories

(1.1m)(3.6m)2.2m3.5m4.5m(6.5m)(6.1m)(10.0m)44.5m42.6m61.6m51.0m54.0m(392.0k)(4.8m)(7.9m)(3.3m)(1.6m)4.6m(4.5m)(13.4m)(3.6m)(6.0m)3.9m

Accounts Payable

1.9m2.6m(314.0k)(1.6m)(1.1m)1.1m155.0k1.0m6.4m6.6m9.5m9.5m9.0m(2.1m)80.0k597.0k263.0k(1.2m)550.0k649.0k546.0k1.8m1.4m(1.2m)

Cash From Operating Activities

31.4m53.5m22.6m43.9m63.6m20.3m47.3m64.6m13.5m48.0m81.7m1.9m55.6m68.7m19.5m57.2m5.5m20.7m71.0m

Purchases of PP&E

(5.8m)(8.6m)(2.2m)(3.4m)(6.8m)(872.0k)(3.0m)(6.3m)(9.0m)(13.7m)(26.0m)(3.4m)(7.0m)(9.2m)(2.9m)(6.6m)(2.6m)(7.1m)(11.4m)

Cash From Investing Activities

(5.8m)(8.6m)(2.2m)(3.3m)(6.7m)(2.0m)(5.2m)(9.6m)(8.9m)(13.2m)(25.4m)(3.3m)(6.7m)(8.9m)(2.6m)(43.2m)32.5m53.8m52.6m

Short-term Borrowings

(599.0k)(5.0m)(72.5m)(72.5m)(3.5m)(3.5m)(5.0m)(5.0m)(5.0m)

Cash From Financing Activities

(25.3m)(32.6m)176.0k(25.6m)(31.2m)(17.9m)(15.9m)(10.1m)1.1m(64.9m)(63.7m)(50.1m)(3.3m)(2.4m)(31.4m)(59.3m)(151.7m)

Net Change in Cash

722.0k12.1m20.8m15.2m26.2m208.0k25.2m44.5m7.3m(30.8m)(8.7m)546.0k53.6m16.0m10.8m17.0m(31.7m)

Interest Paid

9.0k10.0k11.0k147.0k317.0k317.0k2.0k6.0k9.0k2.0k4.0k5.0k7.0k10.0k

Income Taxes Paid

13.5m19.3m741.0k13.3m25.0m1.1m21.0m25.6m8.7m10.1m9.5m10.3m8.6m28.1m41.1m10.1m20.9m40.5m19.5m46.5m10.2m35.1m45.7m

USANA Health Sciences Ratios

USDY, 2019

Revenue/Employee

555.2k

Financial Leverage

1.5 x

USANA Health Sciences Employee Rating

4.0185 votes
Culture & Values
4.3
Work/Life Balance
4.5
Senior Management
3.9
Salary & Benefits
4.0
Career Opportunities
4.0
Source